DGAP-News: MAX Automation SE
/ Key word(s): Quarterly / Interim Statement/9 Month figures
PRESS RELEASE
The very positive development of the order situation in the first half of the year continued in the third quarter despite the still challenging general conditions. In the first nine months of 2021, order intake of the MAX Group rose by 44.5% to mEUR 304.7 (9M 2020: mEUR 210.8) due to very strong demand, particularly from the MAX Group portfolio companies in medical technology, in the Environmental Technologies segment and in packaging automation. Order intake in the Process Technologies segment (+32.2%) returned to its pre-corona level. It was achieved mainly through catch-up effects in dispensing technology and hot riveting. Environmental Technologies (+41.6%) also benefited from catch-up effects and higher oil prices as demand remained high. Growth in the Evolving Technologies segment (+109.5%) was driven by medical technology as well as packaging and press automation. Order intake in Non-Core (-35.9%) continued to decline as anticipated as a result of the closure of the IWM businesses. Overall, the MAX Group's order backlog increased by 56.0% to mEUR 285.8 (30 September 2020: mEUR 183.2) MAX Group's sales were slightly lower than expected at mEUR 229.3 (9M 2020: mEUR 225.1), up 1.9% year-on-year. This was mainly due to the current bottlenecks in the global supply chains and the resulting postponements of project acceptances by customers. Process Technologies reported a 6.0% increase in sales to mEUR 39.8 (9M 2020: mEUR 37.6). In the Environmental Technologies segment, delayed material deliveries led to postponements in project completions and thus to a 3.8% weaker sales development to mEUR 80.5 (9M 2020: mEUR 83.7). Evolving Technologies achieved a 12.7% increase in sales to mEUR 88.4 (9M 2020: mEUR 78.5). As anticipated, sales in the Non-Core segment declined by 20.0% to mEUR 21.9 (9M 2020: mEUR 27.4), mainly due to the closure of the IWM companies. The MAX Group achieved a 44.1% improvement in operating earnings before interest, taxes, depreciation, and amortization (EBITDA) to mEUR 10.6 in the nine-month period of 2021 (9M 2020: mEUR 7.3). Burdens from the Non-Core business were actively reduced further. Supported by projects in dispensing technology and strong service business, increased sales in the Process Technologies segment led to an 8.7% rise in EBITDA to mEUR 5.5 (9M 2020: mEUR 5.0). Environmental Technologies recorded a decline in EBITDA of 5.1% to mEUR 8.6 (9M 2020: mEUR 9.1). Catch-up effects are expected here in the fourth quarter. The overall positive developments in the Evolving Technologies segment were offset by higher expenses for projects in Robotics, which led to a 43.5% decline in EBITDA to mEUR 4.4 (9M 2020: mEUR 7.7). In the Non-Core segment, EBITDA improved to mEUR -0.7 (9M 2020: mEUR -8.1) due to the discontinuation of burdens from the IWM companies. The operating cash flow of the MAX Group improved by 51.1% to mEUR 9.7 (9M 2020: mEUR 6.4). This was mainly due to high advance payments in the Environmental Technologies and Evolving Technologies segments. Net debt decreased by 18.9% to mEUR 87.1 (30 September 2020: mEUR 107.5), while working capital was simultaneously reduced. Cash and cash equivalents declined to mEUR 34.1 (30 September 2020: mEUR 42.3), mainly as a result of the further repayment of liabilities from the syndicated loan. "We managed to continue the positive development of the MAX Group of the first half of the year. Thanks to the well-filled order books, we are very confident of achieving our targets for the current financial year. Without the bottlenecks in the global supply chains, higher growth in sales and earnings would have been possible in the first nine months. In the fourth quarter of 2021 and the first quarter of 2022, we will make up for this in all segments. The development in the first nine months of the year shows that we are well-positioned with our portfolio companies. The positioning in profitable niches in line with macro trends such as MedTec, GreenTec and e-Mobility promises further growth potential for the MAX Group," said Dr. Christian Diekmann, Managing Director and CEO/CFO of MAX Automation SE. The MAX Group continues to expect high demand dynamics in its portfolio companies. Assuming that price increases and bottlenecks in the supply chains do not increase further and thus burden the business performance of the MAX Group, the Managing Directors adhere to the annual forecast and continue to expect a strong increase in sales for financial year 2021 compared to the previous year (2020: mEUR 307.0). For operating earnings before interest, taxes, depreciation, and amortization (EBITDA), the Managing Directors continue to assume a strong increase compared to the previous year (2020: mEUR 5.7). The complete interim statement for the nine-month period of 2021 of MAX Automation SE is available for download at https://www.maxautomation.com/en/investor-relations/financial-reports/.
04.11.2021 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. |
Language: | English |
Company: | MAX Automation SE |
Breite Straße 29-31 | |
40213 Düsseldorf | |
Germany | |
Phone: | +49 (0)211 90991-0 |
Fax: | +49 (0)211 90991-11 |
E-mail: | investor.relations@maxautomation.com |
Internet: | www.maxautomation.com |
ISIN: | DE000A2DA588 |
WKN: | A2DA58 |
Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange; BX |
EQS News ID: | 1245814 |
End of News | DGAP News Service |
|
1245814 04.11.2021
The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.
The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.
If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.
For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.
1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.